Â
Latest Mouth Ulcer Treatment Companies Update
August 2023: Otsuka Pharmaceutical Co., Ltd. announces positive Phase 3 trial results for their topical gel containing sucralfate (commonly used for treating stomach ulcers) for treating recurrent aphthous stomatitis (canker sores), a common type of mouth ulcer.May 2023: GlaxoSmithKline (GSK) acquires Innovate Biopharmaceuticals, gaining access to their investigational drug, IB204, a potential treatment for oral lichen planus, another type of mouth ulcer.April 2023: OraGen Pharmaceuticals expands its oral care product portfolio with the launch of OraSootheâ„¢, a new topical oral pain reliever specifically formulated for mouth ulcers.February 2024: The American Academy of Oral and Maxillofacial Surgery (AAOMS) annual meeting will feature presentations on the latest advancements in oral healthcare, including management of mouth ulcers.July 2024: The International Association for Dental Research (IADR) General Session will showcase research on various oral health topics, potentially including mouth ulcer management.
Â
List of Mouth Ulcer Treatment Key Companies in the Market
- Pfizer Inc.
- Church & Dwight Co.Inc.
- 3M
- Taro Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
- BLISTEX INC.
- GlaxoSmithKline plc.
- ECR Pharmaceuticals
- Sannova
- Reckitt Benckiser
- Sunstar
- Blairex Laboratories
- Sanjin Pharmaceutical
- Joincare Pharmaceutical
- Sinclair Pharma
- Colgate-Palmolive Company